SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $281,946 | -66.8% | 13,700 | -24.3% | 0.00% | -100.0% |
Q2 2023 | $850,157 | +151173.5% | 18,100 | +35.1% | 0.00% | 0.0% |
Q1 2023 | $562 | +10.0% | 13,400 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $511 | -99.9% | 13,400 | -25.1% | 0.00% | 0.0% |
Q3 2022 | $709,000 | +50.2% | 17,900 | +24.3% | 0.00% | 0.0% |
Q2 2022 | $472,000 | +1.9% | 14,400 | +6.7% | 0.00% | 0.0% |
Q1 2022 | $463,000 | -72.1% | 13,500 | -64.8% | 0.00% | -50.0% |
Q4 2021 | $1,659,000 | -17.6% | 38,363 | -15.9% | 0.00% | 0.0% |
Q3 2021 | $2,013,000 | -38.9% | 45,593 | -21.9% | 0.00% | -60.0% |
Q2 2021 | $3,292,000 | +4.3% | 58,381 | +35.6% | 0.01% | 0.0% |
Q1 2021 | $3,155,000 | -23.6% | 43,050 | -7.5% | 0.01% | -16.7% |
Q4 2020 | $4,127,000 | +48.6% | 46,551 | +0.0% | 0.01% | -14.3% |
Q3 2020 | $2,777,000 | +47.9% | 46,542 | +3.6% | 0.01% | +40.0% |
Q2 2020 | $1,877,000 | -9.1% | 44,922 | -35.8% | 0.01% | -16.7% |
Q1 2020 | $2,065,000 | -53.6% | 70,000 | +40.0% | 0.01% | -50.0% |
Q4 2018 | $4,451,000 | -31.1% | 50,011 | +9.3% | 0.01% | -20.0% |
Q3 2018 | $6,464,000 | -73.2% | 45,760 | -68.7% | 0.02% | -82.8% |
Q4 2017 | $24,097,000 | +405.6% | 146,298 | +91.3% | 0.09% | +383.3% |
Q3 2017 | $4,766,000 | -17.4% | 76,484 | +4.7% | 0.02% | -33.3% |
Q2 2017 | $5,769,000 | +134.0% | 73,080 | +51.4% | 0.03% | +125.0% |
Q4 2016 | $2,465,000 | -5.8% | 48,280 | -16.1% | 0.01% | 0.0% |
Q3 2016 | $2,618,000 | – | 57,520 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
RA Capital Management | 455,173 | $74,972,000 | 6.27% |
Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |